BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17485710)

  • 1. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    Vardy J; Rourke S; Tannock IF
    J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function after chemotherapy in adults with solid tumours.
    Vardy J; Tannock I
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
    Tannock IF; Ahles TA; Ganz PA; Van Dam FS
    J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functions in long-term survivors of ovarian cancer.
    Correa DD; Zhou Q; Thaler HT; Maziarz M; Hurley K; Hensley ML
    Gynecol Oncol; 2010 Nov; 119(2):366-9. PubMed ID: 20630576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
    Shilling V; Jenkins V; Trapala IS
    Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study.
    Minisini AM; De Faccio S; Ermacora P; Andreetta C; Fantinel R; Balestrieri M; Piga A; Puglisi F
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):71-9. PubMed ID: 18394917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive changes in cancer survivors.
    Correa DD; Ahles TA
    Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
    Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
    Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term cognitive function following chemotherapy in patients with testicular cancer.
    Pedersen AD; Rossen P; Mehlsen MY; Pedersen CG; Zachariae R; von der Maase H
    J Int Neuropsychol Soc; 2009 Mar; 15(2):296-301. PubMed ID: 19203434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive impairments and breast cancer: a critical review of the literature].
    Vandenbossche S; Fery P; Razavi D
    Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.